We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 37 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. null/null
  3. Tohoku Techno Arch Co., Ltd. Miyagi//Educational and Research Institutions
  4. 4 バイオマテックジャパン Hokkaido//Pharmaceuticals and Biotechnology
  5. 5 KANTO CHEMICAL CO., INC. Biochemical Dept Tokyo//Chemical
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.

  1. Pharmaceutical CDMO services 大塚化学
  2. Ouchi Shinko Chemical Industry Co., Ltd. 須賀川市 経済環境部商工課
  3. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  4. Natural Proteoglycan, the Herbal Medicine of the Sea バイオマテックジャパン
  5. 4 For various titrations! The titration "indicator" specified in JIS K8001. KANTO CHEMICAL CO., INC. Biochemical Dept

medicine Product List

376～390 item / All 589 items

Displayed results
[Research Material] Global Market for Diffuse Large B-Cell Lymphoma Treatment Drugs

[Research Material] Global Market for Diffuse Large B-Cell Lymphoma Treatment Drugs

Global Market for Diffuse Large B-Cell Lymphoma Treatment Drugs: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone ...

This research report (Global Diffuse Large B Cell Lymphoma Drug Market) investigates and analyzes the current status and outlook for the global market of diffuse large B cell lymphoma treatment drugs over the next five years. It includes information on the overview of the global diffuse large B cell lymphoma treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Rituxan, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for diffuse large B cell lymphoma treatment drugs. It also includes the market share of major companies in the diffuse large B cell lymphoma treatment drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Essential Tremor Treatment

[Research Material] The Global Market for Essential Tremor Treatment

World Market for Essential Tremor Treatment: NBI-640756, SAGE-217, Sepranolone, Others, Research Centers, Clinics, Hospitals, Others

This research report (Global Essential Tremor Treatment Market) investigates and analyzes the current state and outlook for the global essential tremor treatment market over the next five years. It includes information on the overview of the global essential tremor treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the essential tremor treatment market include NBI-640756, SAGE-217, sepranolone, and others, while the segments by application cover research centers, clinics, hospitals, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for essential tremor treatment. It also includes the market share of major companies in essential tremor treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Rett Syndrome Treatment

[Research Material] Global Market for Rett Syndrome Treatment

World Market for Rett Syndrome Treatment: Antiepileptic Drugs, Antiepileptic Drugs, Sedatives and Hypnotics, Others, Hospitals, Clinics, Others

This research report (Global Rett Syndrome Treatment Market) investigates and analyzes the current state and outlook for the global market for Rett syndrome treatment over the next five years. It includes information on the overview of the global Rett syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Rett syndrome treatment market include antiepileptic drugs, anticonvulsants, sedative-hypnotics, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Rett syndrome treatment. It also includes the market share of major companies in Rett syndrome treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Amantadine Hydrochloride Oral Medication

[Research Material] Global Market for Amantadine Hydrochloride Oral Medication

Global Market for Amantadine Hydrochloride Oral Medications: Tablets, Capsules, Syrups, Parkinson's Disease, Influenza

This research report (Global Amantadine HCl Oral Market) investigates and analyzes the current status and outlook for the global market of amantadine hydrochloride oral medications over the next five years. It includes information on the overview of the global amantadine hydrochloride oral medication market, trends of key companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include tablets, capsules, and syrup, while the segments by application focus on Parkinson's disease and influenza. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of amantadine hydrochloride oral medications. It also includes the market share of major companies in the amantadine hydrochloride oral medication sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Zika Virus Infection Treatment Drugs

[Research Material] Global Market for Zika Virus Infection Treatment Drugs

Global Market for Zika Virus Infection Treatments: Oral Medications, Injectable Medications, Hospitals, Home Healthcare, Clinics, Others

This research report (Global Zika Virus Infection Drug Market) investigates and analyzes the current status and outlook for the global market for Zika virus infection treatments over the next five years. It includes information on the overview of the global Zika virus infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include oral medications and injectables, while the segments by application cover hospitals, home healthcare, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Zika virus infection treatments. It also includes the market share of major companies in the Zika virus infection treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Terbinafine Hydrochloride Medication

[Research Material] Global Market for Terbinafine Hydrochloride Medication

World Market for Terbinafine Hydrochloride: Topical, Oral, Nail Infections, Toenail Infections, Others

This research report (Global Terbinafine Hydrochloride Drug Market) investigates and analyzes the current status and outlook for the global terbinafine hydrochloride drug market over the next five years. It includes information on the overview of the global terbinafine hydrochloride drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on topical and oral forms, while the segments by application target nail infections, toenail infections, and others. The regional segments calculate the market size of terbinafine hydrochloride drugs by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the terbinafine hydrochloride drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Gene Therapy Medicine

[Research Material] The Global Market for Gene Therapy Medicine

World Market for Gene Therapy Medicine: Oral, Injection, Cancer, Monogenic, Infectious Diseases, Cardiovascular Diseases, Others

This research report (Global Gene Therapy Medicine Market) investigates and analyzes the current state and future outlook of the global gene therapy medicine market over the next five years. It includes information on the overview of the global gene therapy medicine market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on oral and injection methods, while the segments by application target cancer, monogenic diseases, infectious diseases, cardiovascular diseases, and others. The regional segments calculate the market size of gene therapy medicine by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in gene therapy medicine, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Progressive Ataxia and Muscle Weakness

[Research Material] The Global Market for Treatment of Progressive Ataxia and Muscle Weakness

Global Market for Treatment of Progressive Ataxia and Muscle Weakness: Monoclonal Antibodies, Small Molecule Technology, Friedreich's Ataxia, Hereditary Neuropathies ...

This research report (Global Treatment for Syndromes of Progressive Ataxia and Weakness Disorders Market) investigates and analyzes the current status and outlook for the global market for the treatment of progressive ataxia and weakness disorders over the next five years. It includes information on the overview of the global market for the treatment of progressive ataxia and weakness disorders, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on monoclonal antibodies and small molecule technology, while the segments by application target Friedreich's ataxia, hereditary neuropathy, Machado-Joseph disease, progressive bulbar palsy, multiple sclerosis, and others. The regional segments calculate the market size for the treatment of progressive ataxia and weakness disorders by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Document] Global Market for Composite Calamine Lotion

[Research Document] Global Market for Composite Calamine Lotion

Global Market for Compound Calamine Lotion: 50ml, 100ml, Urticaria, Eczema, Others

This research report (Global Compound Calamine Lotion Market) investigates and analyzes the current status and outlook for the global market of compound calamine lotion over the next five years. It includes information on the overview of the global compound calamine lotion market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on 50ml and 100ml, while the segments by application target urticaria, eczema, and others. The regional segments calculate the market size of compound calamine lotion by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the compound calamine lotion sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Plasma-Derived Therapies

[Research Material] Global Market for Plasma-Derived Therapies

World Market for Plasma-Derived Therapies: Albumin, Immunoglobulin, Factor VIII, Others, Hemophilia, Primary Immunodeficiency (PID), Idiopathic Blood ...

This research report (Global Plasma-derived Therapies Market) investigates and analyzes the current status and outlook for the global plasma-derived therapies market over the next five years. It includes information on the overview of the global plasma-derived therapies market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the plasma-derived therapies market include albumin, immunoglobulin, factor VIII, and others, while the segments by application cover hemophilia, primary immunodeficiency (PID), idiopathic thrombocytopenic purpura (ITP), COVID-19, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for plasma-derived therapies. The report also includes the market share of major companies in plasma-derived therapies, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Head and Neck Cancer Treatment Drugs/Treatments

[Research Material] Global Market for Head and Neck Cancer Treatment Drugs/Treatments

Head and neck cancer treatment drugs/treatment global market: PD inhibitors, microtubule inhibitors, EGFR inhibitors, surgery, radiation therapy, chemotherapy, immunotherapy.

This research report (Global Head and Neck Cancer Drugs/Therapeutics Market) investigates and analyzes the current status and outlook for the global market of head and neck cancer treatment drugs/therapeutics over the next five years. It includes information on the overview of the global head and neck cancer treatment drugs/therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the head and neck cancer treatment drugs/therapeutics market focus on PD inhibitors, microtubule inhibitors, and EGFR inhibitors, while the segments by application target surgery, radiation therapy, chemotherapy, and immunotherapy. The regional segments calculate the market size for head and neck cancer treatment drugs/therapeutics by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the head and neck cancer treatment drugs/therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Amlodipine Besylate

[Research Material] Global Market for Amlodipine Besylate

World Market for Amlodipine Besylate: 2.5mg, 5mg, 10mg, Hypertension, Heart Disease

This research report (Global Amlodipine Besylate Market) investigates and analyzes the current state and outlook for the global market of amlodipine besylate over the next five years. It includes information on the overview of the global amlodipine besylate market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the amlodipine besylate market focus on 2.5mg, 5mg, and 10mg, while the segments by application target hypertension and heart disease. The regional segments calculate the market size of amlodipine besylate by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the amlodipine besylate market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Gout Treatment Drugs

[Research Material] Global Market for Gout Treatment Drugs

World Market for Gout Treatment Drugs: NSAIDs, Corticosteroids, Colchicine, Uric Acid Lowering Drugs, Acute Gout, Chronic Gout

This research report (Global Gout Therapeutics Market) investigates and analyzes the current status and outlook for the global market for gout therapeutics over the next five years. It includes information on the overview of the global gout therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include NSAIDs, corticosteroids, colchicine, and urate-lowering drugs, while the segments by application focus on acute gout and chronic gout. The regional segments calculate the market size for gout therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in gout therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Fabry Disease Treatment

[Research Material] The Global Market for Fabry Disease Treatment

Global Market for Fabry Disease Treatment: Enzyme Replacement Therapy (ERT), Chaperone Therapy, Substrate Reduction Therapy (SRT), Others, Hospitals, Clinics, Others

This research report (Global Fabry Disease Treatment Market) investigates and analyzes the current status and outlook for the global Fabry disease treatment market over the next five years. It includes information on the overview of the global Fabry disease treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Fabry disease treatment market include enzyme replacement therapy (ERT), chaperone therapy, substrate reduction therapy (SRT), and others, while the segments by application include hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Fabry disease treatment. It also includes the market share of major companies in Fabry disease treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs

[Research Material] Global Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs

World Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs: Afinitor (Everolimus), Avastin (Bevacizumab), Cabomety...

This research report (Global Kidney Cancer and Renal Cell Carcinoma (RCC)) investigates and analyzes the current status and outlook for the global market of kidney cancer and renal cell carcinoma (RCC) treatment drugs over the next five years. It includes information on the overview of the global kidney cancer and renal cell carcinoma (RCC) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Afinitor (everolimus), Avastin (bevacizumab), Cabometyx (cabozantinib), Inlyta (axitinib), Nexavar (sorafenib), Proleukin (aldesleukin), Torisel (temsirolimus), Sutent (sunitinib), and Votrient (pazopanib). The segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.